MedTrace Logo

Hemospec Device for Sepsis Diagnosis

NCT03350113 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 129

Last updated 2018-05-02

No results posted yet for this study

Summary

A diagnostic devise, namely HemoSpec, had been developed that integrates clinical information, along with information on circulating protein biomarkers and the morphology of white blood cells to achieve early diagnosis of sepsis. The current study is aiming to validate and improve performance of HemoSpec for the rapid assessment of the critically ill patient in the Emergency Department.

Conditions

Interventions

DEVICE

Blood sampling for analysis

Blood Sampling for Analysis

Sponsors & Collaborators

  • General Hospital of Lamia

    collaborator OTHER

  • University of Jena

    collaborator OTHER

  • University of Athens

    lead OTHER

Principal Investigators

  • Evangelos J Giamarellos-Bourboulis, MD, PhD · National and Kapodistrian University of Athens

  • Magdalini Bristianou, MD, PhD · General Hospital of Lamia

  • Michael Bauer, MD, PhD · Jena University Hospital

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-10-02
Primary Completion
2018-04-30
Completion
2018-04-30

Countries

  • Germany
  • Greece

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03350113 on ClinicalTrials.gov